Li Fajun, Li Haifeng, Su Xin, Liang Hongsen, Wei Li, Shi Donglei, Zhang Junhang, Wang Zhaojun
Department of Critical Care Medicine, The First People's Hospital of Kunshan, Kunshan, China.
Department of Anesthesiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Front Oncol. 2022 Aug 15;12:887011. doi: 10.3389/fonc.2022.887011. eCollection 2022.
The incidence and mortality trends of esophageal cancer (EC) remain unknown in China. This study aimed to describe the trend in incidence and mortality of EC in China.
We extracted age-standardized rates and numbers of EC in China for 1990-2019 from the Global Burden of Disease study 2019. The age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) were calculated to describe the trends, while the annual percentage of change and the average annual percent change (AAPC) were analyzed by the joinpoint regression analysis. The incidence and mortality data were analyzed age-period-cohort model analysis.
The ASIR and ASMR decreased slightly before 1999, then increased from 1999 to 2004, and decreased again thereafter, with overall AAPC values of -2.5 (-2.8, -2.1) for females and -0.9 (-1.1, -0.8) for males regarding incidence, with overall AAPC values of -3.1 (-3.3, -2.9) for females and -1.2 (-1.3, -1.1) for males regarding mortality. As a whole, the relative risk (RR) of EC increased with age in both females and males regarding incidence and mortality, except for the 80-84-year-old age group in females and the 85-89-year-old age group in males regarding incidence, where they began to decrease. The RR of EC increased with age in females and males regarding mortality, except for the 85-89-year-old age group in males. The time period showed a trend of first rising and then decreasing, and the RR of time period effect was lower in 2015 than that in 1990 in females regarding both incidence and mortality, whereas males showed a significant upward trend in both incidence and mortality. The birth cohort effect showed an overall downward trend.
The overall incidence and mortality of EC in China shows an increased and then decreased trend from 1990 to 2019. The AAPC decreased in incidence and mortality from 1990 to 2019. The RR of incidence and mortality of EC in China is greatly affected by age in both sexes, by time period in male, we should be paid more attention to.
食管癌(EC)在中国的发病率和死亡率趋势尚不清楚。本研究旨在描述中国食管癌发病率和死亡率的趋势。
我们从《2019年全球疾病负担研究》中提取了1990 - 2019年中国食管癌的年龄标准化率和病例数。计算年龄标准化发病率(ASIR)和年龄标准化死亡率(ASMR)以描述趋势,同时通过连接点回归分析分析年度变化百分比和平均年度变化百分比(AAPC)。发病率和死亡率数据采用年龄 - 时期 - 队列模型分析。
1999年前ASIR和ASMR略有下降,然后在1999年至2004年上升,此后再次下降,女性发病率的总体AAPC值为 - 2.5(- 2.8,- 2.1),男性为 - 0.9(- 1.1,- 0.8);女性死亡率的总体AAPC值为 - 3.1(- 3.3,- 2.9),男性为 - 1.2(- 1.3,- 1.1)。总体而言,无论男性还是女性,食管癌的相对风险(RR)在发病率和死亡率方面均随年龄增加而增加,但女性80 - 84岁年龄组和男性85 - 89岁年龄组的发病率开始下降。无论男性还是女性,食管癌的RR在死亡率方面随年龄增加而增加,但男性85 - 89岁年龄组除外。时间阶段呈先上升后下降趋势,2015年女性发病率和死亡率的时间阶段效应RR均低于1990年,而男性发病率和死亡率均呈显著上升趋势。出生队列效应总体呈下降趋势。
1990年至2019年中国食管癌的总体发病率和死亡率呈先上升后下降趋势。1990年至2019年发病率和死亡率的AAPC下降。中国食管癌发病率和死亡率的RR在两性中受年龄影响很大,在男性中受时间阶段影响很大,应予以更多关注。